Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lena Gezelius"'
Autor:
Karin Tegmark Wisell, Sara Hæggman, Alma Brolund, Lena Gezelius, Barbro Olsson-Liljequist, Petra Edquist, Christian G. Giske
Publikováno v:
Journal of microbiological methods. 83(2)
Fast and reliable epidemiological typing methods for identifying outbreaks and epidemic strains of extended spectrum β-lactamase (ESBL) producing Enterobacteriaceae are urgently needed. The DiversiLab system (DL) has been proposed for these purposes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17cbd3803830f957639cef3cf834928
https://pubmed.ncbi.nlm.nih.gov/20849889
https://pubmed.ncbi.nlm.nih.gov/20849889
Publikováno v:
Scandinavian journal of infectious diseases. 41(6-7)
An outbreak caused by a multiresistant Escherichia coli producing CTX-M-15 ESBL occurred during autumn 2005 and spring 2006 in Kristianstad, a town in southern Sweden. The outbreak comprised 27 cases and was related to an infectious diseases ward and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b8bc05be6b8ced1170c1953f34ef7a
https://pubmed.ncbi.nlm.nih.gov/19396721
https://pubmed.ncbi.nlm.nih.gov/19396721
Publikováno v:
Scandinavian journal of infectious diseases. 33(8)
Mycobacterium marinum is recognized as a cutaneous pathogen requiring antibiotic treatment. We compared the E-test with a reference agar dilution method for susceptibility testing of M. marinum to amikacin, ciprofloxacin, clarithromycin, doxycycline,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d035a89c1a65c723cd54dcd7b9a55513
https://pubmed.ncbi.nlm.nih.gov/11525351
https://pubmed.ncbi.nlm.nih.gov/11525351
Autor:
Kathrine Dornbusch, Lena Gezelius
Publikováno v:
Chemotherapy. 26:418-426
In routine sensitivity testing by the disc diffusion methods, one member for each group of related antibiotics is chosen to represent the group. Each new antibacterial drug is evaluated with respect to its previous antibiotic class disc. In this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054edac3fb73a99128025aa1f9415ae8
https://doi.org/10.1159/000237937
https://doi.org/10.1159/000237937
Autor:
Emily D. Varnell, Theodore Sacks, Itzhak Brook, K.J. Nicolas, Jacqueline Miller, K. R. Reddy, Hideo Asano, Kathrine Dornbusch, Sulagna Sanyal, J. Tselentis, Hitoshi Kojo, Lena Gezelius, Stanley Mirrett, K. Melissinos, Keith S. Morgan, Terri Creagh-Kirk, J. Michel, Barth Reller, J. Papavassiliou, Minoru Nishida, Herbert E. Kaufman, N. J. Legakis, Takeo Murakawa, Supriya Gupta, Arden H. Wander
Publikováno v:
Chemotherapy. 26:I-VII
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2161eda0092b8a23f447dc74f115104
https://doi.org/10.1159/000237934
https://doi.org/10.1159/000237934
Publikováno v:
The Journal of antimicrobial chemotherapy. 22(3)
The in-vitro activity against Gram-negative aerobic bacterial pathogens of a new oral monobactam, tigemonam, was compared with those of amoxycillin/clavulanic acid, aztreonam, cefaclor, ceftazidime, cefuroxime, ciprofloxacin, co-trimoxazole and genta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f8a5e4b32ea6182022581d4900fffa
https://pubmed.ncbi.nlm.nih.gov/3182428
https://pubmed.ncbi.nlm.nih.gov/3182428